Qynapse, a firm headquartered in Paris, France, won FDA clearance for its QyScore software that analyzes brain MRIs for biomarkers of central nervous system diseases. It’s intended to help diagnose and monitor diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis, though it doesn’t do it on its own. The technology alrea (Read more...)